Relx Plc (NYSE:RELX) Sees Large Growth in Short Interest

Relx Plc (NYSE:RELX) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 3,548,893 shares, a growth of 38.1% from the December 31st total of 2,569,360 shares. Based on an average daily trading volume, of 2,413,399 shares, the short-interest ratio is currently 1.5 days. Approximately 0.2% of the shares of the company are sold short. Approximately 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 2,413,399 shares, the short-interest ratio is currently 1.5 days.

Institutional Trading of Relx

A number of large investors have recently added to or reduced their stakes in RELX. NewSquare Capital LLC increased its holdings in shares of Relx by 522.0% in the second quarter. NewSquare Capital LLC now owns 566 shares of the technology company’s stock valued at $31,000 after buying an additional 475 shares in the last quarter. Salomon & Ludwin LLC raised its position in shares of Relx by 1,646.2% during the third quarter. Salomon & Ludwin LLC now owns 681 shares of the technology company’s stock worth $32,000 after purchasing an additional 642 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Relx by 99.3% during the second quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock valued at $33,000 after purchasing an additional 303 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Relx by 191.7% during the third quarter. Nisa Investment Advisors LLC now owns 700 shares of the technology company’s stock valued at $33,000 after purchasing an additional 460 shares during the last quarter. Finally, Harbor Asset Planning Inc. acquired a new position in shares of Relx in the 2nd quarter valued at $37,000. 15.02% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on RELX. Citigroup assumed coverage on shares of Relx in a research report on Monday, January 12th. They set a “neutral” rating for the company. Zacks Research upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Barclays reaffirmed an “overweight” rating on shares of Relx in a report on Tuesday, October 7th. Weiss Ratings reissued a “hold (c+)” rating on shares of Relx in a report on Monday, December 29th. Finally, Deutsche Bank Aktiengesellschaft upgraded Relx from a “hold” rating to a “buy” rating in a research report on Tuesday, December 9th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy”.

Relx Stock Down 1.1%

Shares of RELX stock traded down $0.38 during mid-day trading on Friday, hitting $35.79. 3,475,061 shares of the stock traded hands, compared to its average volume of 2,864,491. Relx has a twelve month low of $35.49 and a twelve month high of $56.33. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. The company’s 50-day simple moving average is $40.49 and its 200-day simple moving average is $44.63.

Relx Company Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.